CD19 CAR T cells - Globe Thesis

Keyword [CD19 CAR T cells] Result: 1 - 17 \| Page: 1 of 1
1.	The Effect Of Hucmscs And Hcbmscs On T Lymphocyte Subsets
2.	Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
3.	Efficacy And Safety Of CD19 CAR-T Cells In Refractory/Recurrent Acute B-Lymphoblastic Leukemia:A Meta-analysis
4.	Optimization Of Gene Editing Conditions For CRISPR/Cas9 And Its Application In The Construction Of Universal CD19.CAR-T Cells
5.	Anti-tumor Effect Of Nanobody-based CD19 CAR-T Cells
6.	Changes Of Cytokine Levels After Relapsed/refractory B-ALL Treated With CD19 CAR-T Cells And Its Clinical Significance
7.	Efficacy And Safety Of CD19 CAR T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphocytic Leukemia With Central Nervous System Invasion
8.	Clinical Study On Donor-derived Targeting CD19 CAR-T Cells For The Treatment Of Relapsed CD19~+ B-cell Acute Lymphoblastic Leukemia After Hematopoietic Stem Cell Transplantation
9.	A Clinical Study Of Fourth-generation CD19-CAR T-cells In The Threapy Of Relapsed/Refractory Adult Acute B Lymphocytic Leukemia
10.	The Effect Of C-Jun Overexpression On The Function Of Cord Blood Derived CD19.CAR-T Cells
11.	Study The Efficacy Of ITK Gene-Edited CD19 CAR T Cells On Chronic Lymphocytic Leukemia
12.	The Efficacy And Safety Study Of CD19 CAR-T Cells Immunotherapy For Relapse/Refractory Diffuse Large B-cell Lymphoma Patients—A Single Center,Single Arm,Open Clinical Study
13.	Role Of Leukemia-derived Extracellular Vesicles In CD19 CAR-T Cell Exhaustion
14.	Study On Generation Of Cord Blood-derived CD19-CAR T Cells And The Anti-tumor Effects In Diffuse Large B-cell Lymphoma
15.	Study On The Mechanism Of Human-derived CD19 CAR-T Cell Therapy In Rescuing Relapsed/Refractory Diffuse Large B-cell Lymphoma Unresponsive To Mouse-derived CD19 CAR-T Cell Therapy
16.	Study On The Effect And Mechanism Of Qiyin Sanliangsan In Assisting CD19 CAR-T Cells In The Treatment Of B-cell Lymphom
17.	Mechanism Of Targeting Glutamine To Regulate Glucose Metabolism Reprogramming And Overcome Immune Escape Of CD19 CAR-T Cells In The Treatment Of Acute Lymphoblastic Leukemia
<<First <Prev Next> Last>> Jump to